PF-08046032
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name PF-08046032
Trade Name
Synonyms PF 08046032|PF08046032
Drug Descriptions

PF-08046032 is an antibody-drug conjugate (ADC) comprising an antibody targeting CD25 linked to monomethyl auristatin E, which potentially results in Treg depletion in the tumor microenvironment and increased antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12).

DrugClasses
CAS Registry Number NA
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
PF-06801591 + PF-08046032 PF-06801591 PF-08046032 0 1
PF-08046032 PF-08046032 0 1


Additional content available in Icon for CKB-BoostCKB BOOST